ConvaTec Group (LON:CTEC) Hits New 12-Month Low – What’s Next?

ConvaTec Group PLC (LON:CTEC)’s share price hit a new 52-week low on Thursday . The company traded as low as GBX 195.50 and last traded at GBX 195.80, with a volume of 18188504 shares trading hands. The stock had previously closed at GBX 202.80.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. UBS Group reaffirmed a “buy” rating and issued a GBX 375 price target on shares of ConvaTec Group in a research note on Monday, May 18th. Stifel Nicolaus reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, March 11th. Citigroup decreased their price target on shares of ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating on the stock in a research note on Monday, May 18th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, April 8th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a GBX 325 target price on shares of ConvaTec Group in a research note on Friday, May 15th. Eight analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of GBX 308.78.

ConvaTec Group Stock Performance

The stock has a market capitalization of £3.96 billion, a PE ratio of 23.59, a price-to-earnings-growth ratio of 0.93 and a beta of 0.78. The firm’s fifty day moving average is GBX 217.15 and its 200-day moving average is GBX 229.28. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 106.19.

Insider Transactions at ConvaTec Group

In related news, insider Jonny Mason acquired 50,000 shares of ConvaTec Group stock in a transaction that occurred on Tuesday, May 26th. The shares were purchased at an average cost of GBX 201 per share, for a total transaction of £100,500. Company insiders own 0.95% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.